332 related articles for article (PubMed ID: 12065722)
21. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.
Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM
J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980
[TBL] [Abstract][Full Text] [Related]
22. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells.
Funatsu T; Suzuki K; Goto M; Arai Y; Kakuta H; Tanaka H; Yasuda S; Ida M; Nishijima S; Miyata K
Atherosclerosis; 2001 Jul; 157(1):107-15. PubMed ID: 11427209
[TBL] [Abstract][Full Text] [Related]
23. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
24. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress.
Baena M; Sangüesa G; Hutter N; Sánchez RM; Roglans N; Laguna JC; Alegret M
Biochim Biophys Acta; 2015 Feb; 1851(2):107-16. PubMed ID: 25463011
[TBL] [Abstract][Full Text] [Related]
25. Oxidized frying oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4 A1 genes in rats and activates PPARalpha.
Chao PM; Chao CY; Lin FJ; Huang C
J Nutr; 2001 Dec; 131(12):3166-74. PubMed ID: 11739861
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar.
Hegarty BD; Furler SM; Oakes ND; Kraegen EW; Cooney GJ
Endocrinology; 2004 Jul; 145(7):3158-64. PubMed ID: 15059948
[TBL] [Abstract][Full Text] [Related]
28. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Chan DC; Watts GF; Barrett PH; Beilin LJ; Redgrave TG; Mori TA
Diabetes; 2002 Aug; 51(8):2377-86. PubMed ID: 12145148
[TBL] [Abstract][Full Text] [Related]
29. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
[TBL] [Abstract][Full Text] [Related]
31. Traditional Chinese Medicine improves dysfunction of peroxisome proliferator-activated receptor alpha and microsomal triglyceride transfer protein on abnormalities in lipid metabolism in ethanol-fed rats.
Kwon HJ; Hyun SH; Choung SY
Biofactors; 2005; 23(3):163-76. PubMed ID: 16410638
[TBL] [Abstract][Full Text] [Related]
32. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.
Alberdi G; Rodríguez VM; Macarulla MT; Miranda J; Churruca I; Portillo MP
Nutrition; 2013 Mar; 29(3):562-7. PubMed ID: 23274094
[TBL] [Abstract][Full Text] [Related]
33. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver.
Xing X; Li D; Chen D; Zhou L; Chonan R; Yamahara J; Wang J; Li Y
Toxicol Appl Pharmacol; 2014 Oct; 280(2):207-15. PubMed ID: 25123789
[TBL] [Abstract][Full Text] [Related]
34. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation.
Mock K; Lateef S; Benedito VA; Tou JC
J Nutr Biochem; 2017 Jan; 39():32-39. PubMed ID: 27768909
[TBL] [Abstract][Full Text] [Related]
35. Enhanced hepatic fatty acid oxidation and upregulated carnitine palmitoyltransferase II gene expression by methyl 3-thiaoctadeca-6,9,12,15-tetraenoate in rats.
Willumsen N; Vaagenes H; Rustan AC; Grav H; Lundquist M; Skattebøl L; Songstad J; Berge RK
J Lipid Mediat Cell Signal; 1997 Nov; 17(2):115-34. PubMed ID: 9459137
[TBL] [Abstract][Full Text] [Related]
36. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster.
Carpentier A; Taghibiglou C; Leung N; Szeto L; Van Iderstine SC; Uffelman KD; Buckingham R; Adeli K; Lewis GF
J Biol Chem; 2002 Aug; 277(32):28795-802. PubMed ID: 12048212
[TBL] [Abstract][Full Text] [Related]
37. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism.
Topping DL; Mayes PA
Biochem J; 1972 Jan; 126(2):295-311. PubMed ID: 5071176
[TBL] [Abstract][Full Text] [Related]
38. Dietary supplementation with myo-inositol reduces hepatic triglyceride accumulation and expression of both fructolytic and lipogenic genes in rats fed a high-fructose diet.
Shimada M; Hibino M; Takeshita A
Nutr Res; 2017 Nov; 47():21-27. PubMed ID: 29241575
[TBL] [Abstract][Full Text] [Related]
39. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
40. Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats.
Sangüesa G; Shaligram S; Akther F; Roglans N; Laguna JC; Rahimian R; Alegret M
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H289-H304. PubMed ID: 27923787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
